Vaccines, blood, antisera, toxins and cultures in   Democratic Republic of the Congo

Exports In 2023, Democratic Republic of the Congo exported $2.28k in Vaccines, blood, antisera, toxins and cultures, making it the 177th largest exporter of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 409th most exported product in Democratic Republic of the Congo. The main destination of Vaccines, blood, antisera, toxins and cultures exports from Democratic Republic of the Congo are: Belgium ($1.17k), Angola ($405), France ($368), South Africa ($180), and Netherlands ($112).

The fastest growing export markets for Vaccines, blood, antisera, toxins and cultures of Democratic Republic of the Congo between 2022 and 2023 were Angola ($405), South Africa ($148), and Netherlands ($112).

Imports In 2023, Democratic Republic of the Congo imported $161M in Vaccines, blood, antisera, toxins and cultures, becoming the 75th largest importer of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 16th most imported product in Democratic Republic of the Congo. Democratic Republic of the Congo imports Vaccines, blood, antisera, toxins and cultures primarily from: Belgium ($68.4M), India ($45.9M), Germany ($15.2M), Switzerland ($12.4M), and France ($10.2M).

The fastest growing import markets in Vaccines, blood, antisera, toxins and cultures for Democratic Republic of the Congo between 2022 and 2023 were India ($23M), Germany ($15M), and Switzerland ($11.5M).